IDOV-Immune for Advanced Solid Tumors

NCT06910657 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Pancreatic Cancer
Melanoma
Ovarian Cancer
Gastric Cancer
Esophageal Cancer
Hepatocellular Carcinoma
Renal Cell Carcinoma
Breast Cancer
Sarcoma
Bladder Cancer
Lung Cancer
Prostate Cancer
Cervical Cancers
Head and Neck Cancers
Adrenal Gland Tumors

Interventions

BIOLOGICAL: IDOV-Immune (oncolytic vaccinia virus)

Sponsor

ViroMissile, Inc.